Skip to main content

UBS Mid Caps USA Equity Fund

UBS Mid Caps USA Equity Fund is an equity fund managed by UBS in the USA – Små og mellomstore selskaper category.

About this fund

Categorised as USA – Små og mellomstore selskaper, UBS Mid Caps USA Equity Fund is an equity fund from UBS.

The fund: 31 years of track record, running since 1995 (share classes may be younger).

It ranks 10 out of 11 in its peer group on return so far this year measured in NOK as of 13.11.2026.

It is run by a team of 3.

The manager states a volatility of 17.5% for the fund.

The reference index is Russell Midcap Growth (net div. reinv.).

Manager
UBS
Category
USA – Små og mellomstore selskaper
Region
US
Sector
Diversified
Style
Small/Mid Blend
SFDR
Article 8
ISIN
LU0049842262
Inception
1995-01-20
Benchmark
Russell Midcap Growth (net div. reinv.)
AUM
211 m USD
Returns
YTD -3.5% · 1Y -3.2% · 3Y 5.7% · 5Y 2.7%

Portfolio managers

Actively managedEquityUS
YTD Return · NOK
−3,5 %from NAV
Calculated NOK return from USD · A (USD) (NOK Calculated)
Last NAV 3 967,03 USD · 13 Nov 2026
Returns by period · NOK · net
ann. 3Y+
−3,5 %
YTD
−3,2 %
1y
+5,7 %
3y, annualised
+2,7 %
5y, annualised
+12,5 %
10y, annualised
Fund size
211,0 mill. USD
Total fund AUM
Management fee
1,44 %
Annual · class A
Ongoing charge
1,88 %
Annual · class A
Performance fee
None
Stated by the manager
Annual cost on platforms
1,47 %–1,48 %
Class A · 3 platforms · net of platform rebate, incl. platform fee, excl. transaction costs
SFDR
Article 8
Sustainability
Launched
Jan 1995
ISIN LU0049842262
BenchmarkRussell Midcap · Growth · Net
Fund website
Risk
Volatility (stated by the manager)17,5 %
Sharpe Ratio0,52
Beta0,96
About the fund
The fund

UBS Mid Caps USA Equity Fund is an actively managed equity fund with a history going back to 1995. The management company, UBS Asset Management, is the asset management division of UBS Group AG, the listed Swiss banking group headquartered in Zürich.

Investment philosophy

The fund invests predominantly in companies with a market capitalisation below USD 10 billion. In selecting stocks, the managers emphasise companies' flexibility and ability to innovate. The managers sit in the team for US large and mid-cap growth equities.

The managers

Peter J. Bye, John Strommen and Katie Thompson co-manage the fund. Bye has managed the fund since 2016 and is based in New York. He joined UBS Asset Management in 2010 and has industry experience going back to 1992. He has particular responsibility for research and stock selection in health care, after about twelve years as a health care equity analyst at Cowen, Citigroup, Wachovia and Jefferies. He has also worked as a quantitative analyst at Putnam Investments and holds a degree from Harvard University. Strommen is based in New York and has been on the fund since 2022. Thompson is based in London and has managed the fund since 2024. Bye and Thompson also manage the UBS USA Growth Equity Fund.

The portfolio

Some of the core positions have held from month to month, including Cencora and DexCom.

FundTelligence description · 18/10/2026
Comparison basis: Ranked among 11 of 17 funds · 6 left out (4 share class outside the rule, 1 history too short, 1 return without a stated date) · returns as of 12 Nov 2026–16 Nov 2026

Portfolio managers

JO
Portfolio Manager
On the fund since Dec 9, 2022
KA
Portfolio Manager
On the fund since Jun 30, 2024
PE
Portfolio Manager
On the fund since Sep 23, 2016

Position in the peer group

US Small/Mid Cap Equities · 17 funds in the peer group. The number ranked and the date are stated per period. 9 of them converted to NOK.

3 of 11 funds ranked on a calculated return

#10/ 11Year to date
-3.50% NOK

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

6 of 17 funds in the group hold no figure for the date and are not counted. 5 funds with older figures: up to 5 business days.

#11/ 121 year
-2.94% NOK

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

5 of 17 funds in the group hold no figure for the date and are not counted. 5 funds with older figures: up to 5 business days.

#6/ 103 years (ann.)
+5.78% NOK

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

7 of 17 funds in the group hold no figure for the date and are not counted. 4 funds with older figures: up to 5 business days.

#6/ 105 years (ann.)
+2.68% NOK

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

7 of 17 funds in the group hold no figure for the date and are not counted. 4 funds with older figures: up to 5 business days.

Comparison basis

Year to date

Comparison basis: Ranked among 11 of 17 funds · 6 left out (4 share class outside the rule, 1 history too short, 1 return without a stated date) · returns as of 12 Nov 2026–16 Nov 2026

1 year

Comparison basis: Ranked among 12 of 17 funds · 5 left out (1 missing return, 2 return as of an earlier date, 2 return without a stated date) · returns as of 12 Nov 2026–16 Nov 2026

3 years (ann.)

Comparison basis: Ranked among 10 of 17 funds · 7 left out (2 share class outside the rule, 1 missing return, 2 return as of an earlier date, 2 return without a stated date) · returns as of 12 Nov 2026–16 Nov 2026

5 years (ann.)

Comparison basis: Ranked among 10 of 17 funds · 7 left out (3 share class outside the rule, 1 missing return, 1 return as of an earlier date, 2 return without a stated date) · returns as of 12 Nov 2026–16 Nov 2026

The positions describe historical return and are not an assessment of the fund, nor investment advice. Past performance is no guarantee of future returns. A position applies only within its own peer group and cannot be compared with positions in other peer groups.

Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.

About our data